Fahed Al Marzooqi
Direktor/Vorstandsmitglied bei VTV THERAPEUTICS INC.
Vermögen: 14 581 $ am 31.05.2024
Profil
Fahed Al Marzooqi currently works at vTv Therapeutics, Inc., as Independent Director from 2022 and G42 Healthcare, as Chief Operating Officer.
Dr. Al Marzooqi also formerly worked at Cleveland Clinic Abu Dhabi, as Chief Administrative Officer.
Dr. Al Marzooqi received his graduate degree from Dalhousie University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
25.06.2024 | 625 ( 0,03% ) | 14 581 $ | 31.05.2024 |
Aktive Positionen von Fahed Al Marzooqi
Unternehmen | Position | Beginn |
---|---|---|
VTV THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 11.07.2022 |
G42 Healthcare
G42 Healthcare Information Technology ServicesTechnology Services Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Fahed Al Marzooqi
Unternehmen | Position | Ende |
---|---|---|
Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi Hospital/Nursing ManagementHealth Services Cleveland Clinic Abu Dhabi engages in the provision of health care services. It provides heart & vascular, neurological, digestive disease, eye, respiratory, and critical care services. The firm also provides surgical subspecialties, medical subspecialties, emergency medicine, anesthesiology, pathology & laboratory medicine, and imaging services. The company was founded in 2006 and is headquartered in Abu Dhabi, United Arab Emirates. | Verwaltungsdirektor | - |
Ausbildung von Fahed Al Marzooqi
Dalhousie University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VTV THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi Hospital/Nursing ManagementHealth Services Cleveland Clinic Abu Dhabi engages in the provision of health care services. It provides heart & vascular, neurological, digestive disease, eye, respiratory, and critical care services. The firm also provides surgical subspecialties, medical subspecialties, emergency medicine, anesthesiology, pathology & laboratory medicine, and imaging services. The company was founded in 2006 and is headquartered in Abu Dhabi, United Arab Emirates. | Health Services |
G42 Healthcare
G42 Healthcare Information Technology ServicesTechnology Services Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022. | Technology Services |